SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-021972
Filing Date
2023-08-03
Accepted
2023-08-03 16:41:22
Documents
82
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20230630_10q.htm   iXBRL 10-Q 1447865
2 EXHIBIT 10.1 FIFTH AMENDMENT TO NOTE PURCHASE AGREEMENT ex_553144.htm EX-10.1 28491
3 EXHIBIT 31.1 ex_534928.htm EX-31.1 8317
4 EXHIBIT 31.2 ex_534929.htm EX-31.2 8342
5 EXHIBIT 32.1 ex_534930.htm EX-32.1 5088
6 EXHIBIT 32.2 ex_534931.htm EX-32.2 5106
  Complete submission text file 0001437749-23-021972.txt   7783738

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20230630.xsd EX-101.SCH 71435
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20230630_cal.xml EX-101.CAL 64067
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20230630_def.xml EX-101.DEF 470097
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20230630_lab.xml EX-101.LAB 426741
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20230630_pre.xml EX-101.PRE 505031
76 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20230630_10q_htm.xml XML 1264595
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 231140825
SIC: 2834 Pharmaceutical Preparations